Gary --

Thanks. I did my OCF main site search using the term "HPV-16" so missed those.

I was pleased to see in the UPI story (last link) that Merck is indeed looking in this. Poor UPI has fallen hard from its glory days and has only very limited distribution; I know the paper where I work (with one of the largest circulations in the US) does not subscribe.

Leslie

April 2006: Husband dx by dentist with leukoplakia on tongue. Oral surgeon's biopsy 4/28/06: Moderate dysplasia; pathology report warned of possible "skip effect." ENT's excisional biopsy (got it all) 5/31/06: SCC in situ/small bit superficially invasive. Early detection saves lives.